<?xml version="1.0" encoding="utf-8"?>
<Return xmlns="http://www.irs.gov/efile" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" returnVersion="2021v4.1" xsi:schemaLocation="http://www.irs.gov/efile">
  <ReturnHeader binaryAttachmentCnt="0">
    <ReturnTs>2023-05-08T15:27:18-07:00</ReturnTs>
    <TaxPeriodEndDt>2022-06-30</TaxPeriodEndDt>
    <PreparerFirmGrp>
      <PreparerFirmEIN>680260103</PreparerFirmEIN>
      <PreparerFirmName>
        <BusinessNameLine1Txt>REGALIA &amp; ASSOCIATES CPAS</BusinessNameLine1Txt>
      </PreparerFirmName>
      <PreparerUSAddress>
        <AddressLine1Txt>103 TOWN COUNTRY DR STE K</AddressLine1Txt>
        <CityNm>DANVILLE</CityNm>
        <StateAbbreviationCd>CA</StateAbbreviationCd>
        <ZIPCd>94526</ZIPCd>
      </PreparerUSAddress>
    </PreparerFirmGrp>
    <ReturnTypeCd>990</ReturnTypeCd>
    <TaxPeriodBeginDt>2021-07-01</TaxPeriodBeginDt>
    <Filer>
      <EIN>942825216</EIN>
      <BusinessName>
        <BusinessNameLine1Txt>Vascular Cures</BusinessNameLine1Txt>
      </BusinessName>
      <BusinessNameControlTxt>VASC</BusinessNameControlTxt>
      <PhoneNum>6503686022</PhoneNum>
      <USAddress>
        <AddressLine1Txt>274 Redwood Shores Parkway 717</AddressLine1Txt>
        <CityNm>Redwood City</CityNm>
        <StateAbbreviationCd>CA</StateAbbreviationCd>
        <ZIPCd>94065</ZIPCd>
      </USAddress>
    </Filer>
    <BusinessOfficerGrp>
      <PersonNm>ISABEL BJORK</PersonNm>
      <PersonTitleTxt>CEO</PersonTitleTxt>
      <SignatureDt>2023-05-08</SignatureDt>
      <DiscussWithPaidPreparerInd>true</DiscussWithPaidPreparerInd>
    </BusinessOfficerGrp>
    <SigningOfficerGrp>
      <PersonFullName>
        <PersonFirstNm>ISABEL</PersonFirstNm>
        <PersonLastNm>BJORK</PersonLastNm>
      </PersonFullName>
      <SSN>999009999</SSN>
    </SigningOfficerGrp>
    <PreparerPersonGrp>
      <PreparerPersonNm>Douglas W Regalia</PreparerPersonNm>
      <PTIN>P00186389</PTIN>
      <PhoneNum>9253140390</PhoneNum>
    </PreparerPersonGrp>
    <AdditionalFilerInformation>
      <TrustedCustomerGrp>
        <TrustedCustomerCd>2</TrustedCustomerCd>
        <AuthenticationAssuranceLevelCd>AAL1</AuthenticationAssuranceLevelCd>
        <IdentityAssuranceLevelCd>IAL1</IdentityAssuranceLevelCd>
        <FederatedAssuranceLevelCd>FAL1</FederatedAssuranceLevelCd>
      </TrustedCustomerGrp>
    </AdditionalFilerInformation>
    <TaxYr>2021</TaxYr>
    <BuildTS>2023-04-26 12:10:37Z</BuildTS>
  </ReturnHeader>
  <ReturnData documentCnt="8">
    <IRS990 documentId="IRS990" referenceDocumentId="IRS990ScheduleO" softwareId="21013475" softwareVersionNum="2021v4.1">
      <PrincipalOfficerNm>Edward Yu</PrincipalOfficerNm>
      <USAddress>
        <AddressLine1Txt>274 Redwood Shores Parkway 717</AddressLine1Txt>
        <CityNm>Redwood City</CityNm>
        <StateAbbreviationCd>CA</StateAbbreviationCd>
        <ZIPCd>94065</ZIPCd>
      </USAddress>
      <GrossReceiptsAmt>2164649</GrossReceiptsAmt>
      <GroupReturnForAffiliatesInd>false</GroupReturnForAffiliatesInd>
      <Organization501c3Ind>X</Organization501c3Ind>
      <WebsiteAddressTxt>www.vascularcures.org</WebsiteAddressTxt>
      <TypeOfOrganizationCorpInd>X</TypeOfOrganizationCorpInd>
      <FormationYr>1982</FormationYr>
      <LegalDomicileStateCd>CA</LegalDomicileStateCd>
      <ActivityOrMissionDesc>OUR MISSION IS TO AMPLIFY THE PATIENT VOICE, ACCELERATE PATIENT-CENTERED RESEARCH, AND CATALYZE INNOVATIVE COLLABORATIONS.</ActivityOrMissionDesc>
      <VotingMembersGoverningBodyCnt>11</VotingMembersGoverningBodyCnt>
      <VotingMembersIndependentCnt>10</VotingMembersIndependentCnt>
      <TotalEmployeeCnt>6</TotalEmployeeCnt>
      <TotalVolunteersCnt>8</TotalVolunteersCnt>
      <TotalGrossUBIAmt>0</TotalGrossUBIAmt>
      <PYContributionsGrantsAmt>349850</PYContributionsGrantsAmt>
      <CYContributionsGrantsAmt>1313014</CYContributionsGrantsAmt>
      <PYProgramServiceRevenueAmt>20160</PYProgramServiceRevenueAmt>
      <CYProgramServiceRevenueAmt>648666</CYProgramServiceRevenueAmt>
      <PYInvestmentIncomeAmt>97559</PYInvestmentIncomeAmt>
      <CYInvestmentIncomeAmt>121981</CYInvestmentIncomeAmt>
      <PYOtherRevenueAmt>48978</PYOtherRevenueAmt>
      <CYOtherRevenueAmt>69791</CYOtherRevenueAmt>
      <PYTotalRevenueAmt>516547</PYTotalRevenueAmt>
      <CYTotalRevenueAmt>2153452</CYTotalRevenueAmt>
      <PYGrantsAndSimilarPaidAmt>262500</PYGrantsAndSimilarPaidAmt>
      <CYGrantsAndSimilarPaidAmt>420267</CYGrantsAndSimilarPaidAmt>
      <CYBenefitsPaidToMembersAmt>0</CYBenefitsPaidToMembersAmt>
      <PYSalariesCompEmpBnftPaidAmt>431780</PYSalariesCompEmpBnftPaidAmt>
      <CYSalariesCompEmpBnftPaidAmt>500290</CYSalariesCompEmpBnftPaidAmt>
      <CYTotalProfFndrsngExpnsAmt>0</CYTotalProfFndrsngExpnsAmt>
      <CYTotalFundraisingExpenseAmt>80993</CYTotalFundraisingExpenseAmt>
      <PYOtherExpensesAmt>112211</PYOtherExpensesAmt>
      <CYOtherExpensesAmt>1136345</CYOtherExpensesAmt>
      <PYTotalExpensesAmt>806491</PYTotalExpensesAmt>
      <CYTotalExpensesAmt>2056902</CYTotalExpensesAmt>
      <PYRevenuesLessExpensesAmt>-289944</PYRevenuesLessExpensesAmt>
      <CYRevenuesLessExpensesAmt>96550</CYRevenuesLessExpensesAmt>
      <TotalAssetsBOYAmt>4123824</TotalAssetsBOYAmt>
      <TotalAssetsEOYAmt>3787443</TotalAssetsEOYAmt>
      <TotalLiabilitiesBOYAmt>563236</TotalLiabilitiesBOYAmt>
      <TotalLiabilitiesEOYAmt>483473</TotalLiabilitiesEOYAmt>
      <NetAssetsOrFundBalancesBOYAmt>3560588</NetAssetsOrFundBalancesBOYAmt>
      <NetAssetsOrFundBalancesEOYAmt>3303970</NetAssetsOrFundBalancesEOYAmt>
      <InfoInScheduleOPartIIIInd>X</InfoInScheduleOPartIIIInd>
      <MissionDesc>OUR MISSION IS TO AMPLIFY THE PATIENT VOICE, ACCELERATE PATIENT-CENTERED RESEARCH, AND CATALYZE INNOVATIVE COLLABORATIONS.</MissionDesc>
      <SignificantNewProgramSrvcInd>false</SignificantNewProgramSrvcInd>
      <SignificantChangeInd>false</SignificantChangeInd>
      <ExpenseAmt>737481</ExpenseAmt>
      <Desc>WE SERVE AS THE FISCAL SPONSOR OF AMERICAN LIMB PRESERVATION SOCIETY. WHEN WE LAUNCHED PROJECT VOICE, IT WAS THE FIRST DIGITAL HEALTH PROGRAM TO IMPROVEOUTCOMES FOR PATIENTS WITH PERIPHERAL ARTERY DISEASE (PAD). PROJECT VOICE WILL 1)BRING PATIENTS INTO THE HEALTHCARE CONVERSATION, MANAGE THEIR OWN HEALTH AND SHAREIN DECISION-MAKING; 2) ENABLE RESEARCHERS TO GATHER PATIENT-REPORTED OUTCOMES DATA,CURRENTLY A CRUCIAL GAP IN BOTH RESEARCH AND HEALTHCARE AND 3) IMPROVEPATIENT-PHYSICIAN PARTNERSHIPS THROUGH HIGHER QUALITY INFORMATION EXCHANGE ANDSHARED DECISION-MAKING. THE ULTIMATE GOAL IS TO IMPROVE OUTCOMES AND LOWERHEALTHCARE COSTS.</Desc>
      <ProgSrvcAccomActy2Grp>
        <ExpenseAmt>410144</ExpenseAmt>
        <Desc>EDUCATION AND COMMUNITY AWARENESS PROGRAMS ARE THE AWARENESS OF THE RISKS, CONSEQUENCES AND NEW TREATMENTS FOR VASCULAR DISEASE. WE EMPHASIZE EMPOWERMENT AND SHARED DECISION-MAKING BEST PRACTICES, HELPING TO ENSURE THAT PATIENTS WITH VASCULAR DISEASE AND THEIR FAMILIES ARE EQUIPPED WITH THE KNOWLEDGE TO MAKE INFORMED DECISIONS ABOUT THEIR HEALTH CARE. WE HAVE A SPECIFIC FOCUS ON PREVENTION AND MAKING RESOURCES ACCESSIBLE TO VULNERABLE POPULATIONS AND COMMUNITIES. Every year, more than 200,000 individuals around the world visit our website to learn about vascular disease and connect to critical resources.(continued on Schedule O)</Desc>
      </ProgSrvcAccomActy2Grp>
      <ProgSrvcAccomActy3Grp>
        <ExpenseAmt>267243</ExpenseAmt>
        <Desc>The Wylie Scholar Program provides 3-year career development grants to outstanding young vascular surgeon-scientists who combine active patient care with academic research. The award supports crucial research that enables them to compete for future research funding. Wylie Scholars become North Americas world-class vascular surgeon-scientists; many are now chiefs at major academic centers, prominent leaders in the field, and play a key role in our programs. Since 1996, weve supported 24 surgeon-scientists at 15 institutions around the country who are transforming patient care. The average return on investment for follow-on research funding is 30:1.</Desc>
      </ProgSrvcAccomActy3Grp>
      <TotalOtherProgSrvcExpenseAmt>444328</TotalOtherProgSrvcExpenseAmt>
      <TotalProgramServiceExpensesAmt>1859196</TotalProgramServiceExpensesAmt>
      <DescribedInSection501c3Ind referenceDocumentId="IRS990ScheduleA">true</DescribedInSection501c3Ind>
      <ScheduleBRequiredInd referenceDocumentId="IRS990ScheduleB">true</ScheduleBRequiredInd>
      <PoliticalCampaignActyInd>false</PoliticalCampaignActyInd>
      <LobbyingActivitiesInd>false</LobbyingActivitiesInd>
      <SubjectToProxyTaxInd>false</SubjectToProxyTaxInd>
      <DonorAdvisedFundInd referenceDocumentId="IRS990ScheduleD">false</DonorAdvisedFundInd>
      <ConservationEasementsInd referenceDocumentId="IRS990ScheduleD">false</ConservationEasementsInd>
      <CollectionsOfArtInd referenceDocumentId="IRS990ScheduleD">false</CollectionsOfArtInd>
      <CreditCounselingInd referenceDocumentId="IRS990ScheduleD">false</CreditCounselingInd>
      <DonorRstrOrQuasiEndowmentsInd referenceDocumentId="IRS990ScheduleD">true</DonorRstrOrQuasiEndowmentsInd>
      <ReportLandBuildingEquipmentInd referenceDocumentId="IRS990ScheduleD">true</ReportLandBuildingEquipmentInd>
      <ReportInvestmentsOtherSecInd referenceDocumentId="IRS990ScheduleD">true</ReportInvestmentsOtherSecInd>
      <ReportProgramRelatedInvstInd referenceDocumentId="IRS990ScheduleD">false</ReportProgramRelatedInvstInd>
      <ReportOtherAssetsInd referenceDocumentId="IRS990ScheduleD">false</ReportOtherAssetsInd>
      <ReportOtherLiabilitiesInd referenceDocumentId="IRS990ScheduleD">true</ReportOtherLiabilitiesInd>
      <IncludeFIN48FootnoteInd referenceDocumentId="IRS990ScheduleD">true</IncludeFIN48FootnoteInd>
      <IndependentAuditFinclStmtInd referenceDocumentId="IRS990ScheduleD">false</IndependentAuditFinclStmtInd>
      <ConsolidatedAuditFinclStmtInd referenceDocumentId="IRS990ScheduleD">true</ConsolidatedAuditFinclStmtInd>
      <SchoolOperatingInd>false</SchoolOperatingInd>
      <ForeignOfficeInd>false</ForeignOfficeInd>
      <ForeignActivitiesInd referenceDocumentId="IRS990ScheduleF">true</ForeignActivitiesInd>
      <MoreThan5000KToOrgInd referenceDocumentId="IRS990ScheduleF">true</MoreThan5000KToOrgInd>
      <MoreThan5000KToIndividualsInd referenceDocumentId="IRS990ScheduleF">false</MoreThan5000KToIndividualsInd>
      <ProfessionalFundraisingInd referenceDocumentId="IRS990ScheduleG">false</ProfessionalFundraisingInd>
      <FundraisingActivitiesInd referenceDocumentId="IRS990ScheduleG">true</FundraisingActivitiesInd>
      <GamingActivitiesInd referenceDocumentId="IRS990ScheduleG">false</GamingActivitiesInd>
      <OperateHospitalInd>false</OperateHospitalInd>
      <GrantsToOrganizationsInd referenceDocumentId="IRS990ScheduleI">true</GrantsToOrganizationsInd>
      <GrantsToIndividualsInd referenceDocumentId="IRS990ScheduleI">false</GrantsToIndividualsInd>
      <ScheduleJRequiredInd>false</ScheduleJRequiredInd>
      <TaxExemptBondsInd>false</TaxExemptBondsInd>
      <EngagedInExcessBenefitTransInd>false</EngagedInExcessBenefitTransInd>
      <PYExcessBenefitTransInd>false</PYExcessBenefitTransInd>
      <LoanOutstandingInd>false</LoanOutstandingInd>
      <GrantToRelatedPersonInd>false</GrantToRelatedPersonInd>
      <BusinessRlnWithOrgMemInd>false</BusinessRlnWithOrgMemInd>
      <BusinessRlnWithFamMemInd>false</BusinessRlnWithFamMemInd>
      <BusinessRlnWith35CtrlEntInd>false</BusinessRlnWith35CtrlEntInd>
      <DeductibleNonCashContriInd>false</DeductibleNonCashContriInd>
      <DeductibleArtContributionInd>false</DeductibleArtContributionInd>
      <TerminateOperationsInd>false</TerminateOperationsInd>
      <PartialLiquidationInd>false</PartialLiquidationInd>
      <DisregardedEntityInd>false</DisregardedEntityInd>
      <RelatedEntityInd>false</RelatedEntityInd>
      <RelatedOrganizationCtrlEntInd>false</RelatedOrganizationCtrlEntInd>
      <TrnsfrExmptNonChrtblRltdOrgInd>false</TrnsfrExmptNonChrtblRltdOrgInd>
      <ActivitiesConductedPrtshpInd>false</ActivitiesConductedPrtshpInd>
      <ScheduleORequiredInd>true</ScheduleORequiredInd>
      <IRPDocumentCnt>3</IRPDocumentCnt>
      <IRPDocumentW2GCnt>0</IRPDocumentW2GCnt>
      <BackupWthldComplianceInd>true</BackupWthldComplianceInd>
      <EmployeeCnt>6</EmployeeCnt>
      <EmploymentTaxReturnsFiledInd>true</EmploymentTaxReturnsFiledInd>
      <UnrelatedBusIncmOverLimitInd>false</UnrelatedBusIncmOverLimitInd>
      <ForeignFinancialAccountInd>false</ForeignFinancialAccountInd>
      <ProhibitedTaxShelterTransInd>false</ProhibitedTaxShelterTransInd>
      <TaxablePartyNotificationInd>false</TaxablePartyNotificationInd>
      <NondeductibleContributionsInd>true</NondeductibleContributionsInd>
      <NondeductibleContriDisclInd>true</NondeductibleContriDisclInd>
      <QuidProQuoContributionsInd>false</QuidProQuoContributionsInd>
      <Form8282PropertyDisposedOfInd>false</Form8282PropertyDisposedOfInd>
      <Form8282FiledCnt>0</Form8282FiledCnt>
      <RcvFndsToPayPrsnlBnftCntrctInd>false</RcvFndsToPayPrsnlBnftCntrctInd>
      <PayPremiumsPrsnlBnftCntrctInd>false</PayPremiumsPrsnlBnftCntrctInd>
      <Form8899Filedind>false</Form8899Filedind>
      <Form1098CFiledInd>false</Form1098CFiledInd>
      <IndoorTanningServicesInd>false</IndoorTanningServicesInd>
      <SubjToTaxRmnrtnExPrchtPymtInd>false</SubjToTaxRmnrtnExPrchtPymtInd>
      <SubjectToExcsTaxNetInvstIncInd>false</SubjectToExcsTaxNetInvstIncInd>
      <InfoInScheduleOPartVIInd>X</InfoInScheduleOPartVIInd>
      <GoverningBodyVotingMembersCnt>11</GoverningBodyVotingMembersCnt>
      <IndependentVotingMemberCnt>10</IndependentVotingMemberCnt>
      <FamilyOrBusinessRlnInd>false</FamilyOrBusinessRlnInd>
      <DelegationOfMgmtDutiesInd>false</DelegationOfMgmtDutiesInd>
      <ChangeToOrgDocumentsInd>false</ChangeToOrgDocumentsInd>
      <MaterialDiversionOrMisuseInd>false</MaterialDiversionOrMisuseInd>
      <MembersOrStockholdersInd>false</MembersOrStockholdersInd>
      <ElectionOfBoardMembersInd>false</ElectionOfBoardMembersInd>
      <DecisionsSubjectToApprovaInd>false</DecisionsSubjectToApprovaInd>
      <MinutesOfGoverningBodyInd>true</MinutesOfGoverningBodyInd>
      <MinutesOfCommitteesInd>true</MinutesOfCommitteesInd>
      <OfficerMailingAddressInd>false</OfficerMailingAddressInd>
      <LocalChaptersInd>false</LocalChaptersInd>
      <Form990ProvidedToGvrnBodyInd>true</Form990ProvidedToGvrnBodyInd>
      <ConflictOfInterestPolicyInd>true</ConflictOfInterestPolicyInd>
      <AnnualDisclosureCoveredPrsnInd>true</AnnualDisclosureCoveredPrsnInd>
      <RegularMonitoringEnfrcInd>true</RegularMonitoringEnfrcInd>
      <WhistleblowerPolicyInd>true</WhistleblowerPolicyInd>
      <DocumentRetentionPolicyInd>true</DocumentRetentionPolicyInd>
      <CompensationProcessCEOInd>true</CompensationProcessCEOInd>
      <CompensationProcessOtherInd>true</CompensationProcessOtherInd>
      <InvestmentInJointVentureInd>false</InvestmentInJointVentureInd>
      <StatesWhereCopyOfReturnIsFldCd>CA</StatesWhereCopyOfReturnIsFldCd>
      <OwnWebsiteInd>X</OwnWebsiteInd>
      <OtherWebsiteInd>X</OtherWebsiteInd>
      <UponRequestInd>X</UponRequestInd>
      <BooksInCareOfDetail>
        <PersonNm>Isabel Bjork-CEO</PersonNm>
        <PhoneNum>6503686022</PhoneNum>
        <USAddress>
          <AddressLine1Txt>274 Redwood Shores Parkway 717</AddressLine1Txt>
          <CityNm>Redwood City</CityNm>
          <StateAbbreviationCd>CA</StateAbbreviationCd>
          <ZIPCd>94065</ZIPCd>
        </USAddress>
      </BooksInCareOfDetail>
      <Form990PartVIISectionAGrp>
        <PersonNm>Megan Patterson</PersonNm>
        <TitleTxt>CEO</TitleTxt>
        <AverageHoursPerWeekRt>40.00</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.00</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>136250</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>LENIMFA CATALAN</PersonNm>
        <TitleTxt>Staff</TitleTxt>
        <AverageHoursPerWeekRt>40.00</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.00</AverageHoursPerWeekRltdOrgRt>
        <ReportableCompFromOrgAmt>100000</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>11678</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Edward Yu</PersonNm>
        <TitleTxt>Board Chair</TitleTxt>
        <AverageHoursPerWeekRt>2.00</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.00</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>David Rae</PersonNm>
        <TitleTxt>Treasurer</TitleTxt>
        <AverageHoursPerWeekRt>2.00</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.00</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Michael Conte MD</PersonNm>
        <TitleTxt>CMO</TitleTxt>
        <AverageHoursPerWeekRt>2.00</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.00</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>LILIA MARTINEZ-COBURN</PersonNm>
        <TitleTxt>Director</TitleTxt>
        <AverageHoursPerWeekRt>2.00</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.00</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Douglas Grey MD</PersonNm>
        <TitleTxt>Director</TitleTxt>
        <AverageHoursPerWeekRt>2.00</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.00</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Kevin Heath</PersonNm>
        <TitleTxt>Director</TitleTxt>
        <AverageHoursPerWeekRt>2.00</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.00</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Wendy R Hitchcock</PersonNm>
        <TitleTxt>Director</TitleTxt>
        <AverageHoursPerWeekRt>2.00</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.00</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Bob Kain</PersonNm>
        <TitleTxt>Director</TitleTxt>
        <AverageHoursPerWeekRt>2.00</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.00</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Julie Lawrence</PersonNm>
        <TitleTxt>Director</TitleTxt>
        <AverageHoursPerWeekRt>2.00</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.00</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>Margaret Wong</PersonNm>
        <TitleTxt>Director</TitleTxt>
        <AverageHoursPerWeekRt>2.00</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.00</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <TotalReportableCompFromOrgAmt>236250</TotalReportableCompFromOrgAmt>
      <TotalOtherCompensationAmt>11678</TotalOtherCompensationAmt>
      <IndivRcvdGreaterThan100KCnt>1</IndivRcvdGreaterThan100KCnt>
      <FormerOfcrEmployeesListedInd>false</FormerOfcrEmployeesListedInd>
      <TotalCompGreaterThan150KInd>false</TotalCompGreaterThan150KInd>
      <CompensationFromOtherSrcsInd>false</CompensationFromOtherSrcsInd>
      <CntrctRcvdGreaterThan100KCnt>0</CntrctRcvdGreaterThan100KCnt>
      <AllOtherContributionsAmt>1313014</AllOtherContributionsAmt>
      <NoncashContributionsAmt>20228</NoncashContributionsAmt>
      <TotalContributionsAmt>1313014</TotalContributionsAmt>
      <ProgramServiceRevenueGrp>
        <Desc>FISCAL SPONSORSHIPS</Desc>
        <BusinessCd>541700</BusinessCd>
        <TotalRevenueColumnAmt>648666</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>648666</RelatedOrExemptFuncIncomeAmt>
      </ProgramServiceRevenueGrp>
      <TotalProgramServiceRevenueAmt>648666</TotalProgramServiceRevenueAmt>
      <InvestmentIncomeGrp>
        <TotalRevenueColumnAmt>121981</TotalRevenueColumnAmt>
        <ExclusionAmt>121981</ExclusionAmt>
      </InvestmentIncomeGrp>
      <IncmFromInvestBondProceedsGrp>
        <TotalRevenueColumnAmt>0</TotalRevenueColumnAmt>
      </IncmFromInvestBondProceedsGrp>
      <RoyaltiesRevenueGrp>
        <TotalRevenueColumnAmt>0</TotalRevenueColumnAmt>
      </RoyaltiesRevenueGrp>
      <NetRentalIncomeOrLossGrp>
        <TotalRevenueColumnAmt>0</TotalRevenueColumnAmt>
      </NetRentalIncomeOrLossGrp>
      <NetGainOrLossInvestmentsGrp>
        <TotalRevenueColumnAmt>0</TotalRevenueColumnAmt>
      </NetGainOrLossInvestmentsGrp>
      <FundraisingGrossIncomeAmt>80988</FundraisingGrossIncomeAmt>
      <FundraisingDirectExpensesAmt>11197</FundraisingDirectExpensesAmt>
      <NetIncmFromFundraisingEvtGrp>
        <TotalRevenueColumnAmt>69791</TotalRevenueColumnAmt>
      </NetIncmFromFundraisingEvtGrp>
      <NetIncomeFromGamingGrp>
        <TotalRevenueColumnAmt>0</TotalRevenueColumnAmt>
      </NetIncomeFromGamingGrp>
      <NetIncomeOrLossGrp>
        <TotalRevenueColumnAmt>0</TotalRevenueColumnAmt>
      </NetIncomeOrLossGrp>
      <OtherRevenueTotalAmt>0</OtherRevenueTotalAmt>
      <TotalRevenueGrp>
        <TotalRevenueColumnAmt>2153452</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>648666</RelatedOrExemptFuncIncomeAmt>
        <ExclusionAmt>121981</ExclusionAmt>
      </TotalRevenueGrp>
      <InfoInScheduleOPartIXInd>X</InfoInScheduleOPartIXInd>
      <GrantsToDomesticOrgsGrp>
        <TotalAmt>320267</TotalAmt>
        <ProgramServicesAmt>320267</ProgramServicesAmt>
      </GrantsToDomesticOrgsGrp>
      <GrantsToDomesticIndividualsGrp>
        <TotalAmt>0</TotalAmt>
      </GrantsToDomesticIndividualsGrp>
      <ForeignGrantsGrp>
        <TotalAmt>100000</TotalAmt>
        <ProgramServicesAmt>100000</ProgramServicesAmt>
      </ForeignGrantsGrp>
      <BenefitsToMembersGrp>
        <TotalAmt>0</TotalAmt>
      </BenefitsToMembersGrp>
      <CompCurrentOfcrDirectorsGrp>
        <TotalAmt>136250</TotalAmt>
        <ProgramServicesAmt>110826</ProgramServicesAmt>
        <ManagementAndGeneralAmt>11980</ManagementAndGeneralAmt>
        <FundraisingAmt>13444</FundraisingAmt>
      </CompCurrentOfcrDirectorsGrp>
      <CompDisqualPersonsGrp>
        <TotalAmt>0</TotalAmt>
      </CompDisqualPersonsGrp>
      <OtherSalariesAndWagesGrp>
        <TotalAmt>303542</TotalAmt>
        <ProgramServicesAmt>246902</ProgramServicesAmt>
        <ManagementAndGeneralAmt>26690</ManagementAndGeneralAmt>
        <FundraisingAmt>29950</FundraisingAmt>
      </OtherSalariesAndWagesGrp>
      <PensionPlanContributionsGrp>
        <TotalAmt>0</TotalAmt>
      </PensionPlanContributionsGrp>
      <OtherEmployeeBenefitsGrp>
        <TotalAmt>28991</TotalAmt>
        <ProgramServicesAmt>22763</ProgramServicesAmt>
        <ManagementAndGeneralAmt>3191</ManagementAndGeneralAmt>
        <FundraisingAmt>3037</FundraisingAmt>
      </OtherEmployeeBenefitsGrp>
      <PayrollTaxesGrp>
        <TotalAmt>31507</TotalAmt>
        <ProgramServicesAmt>25140</ProgramServicesAmt>
        <ManagementAndGeneralAmt>2998</ManagementAndGeneralAmt>
        <FundraisingAmt>3369</FundraisingAmt>
      </PayrollTaxesGrp>
      <FeesForServicesManagementGrp>
        <TotalAmt>0</TotalAmt>
      </FeesForServicesManagementGrp>
      <FeesForServicesLegalGrp>
        <TotalAmt>0</TotalAmt>
      </FeesForServicesLegalGrp>
      <FeesForServicesAccountingGrp>
        <TotalAmt>38633</TotalAmt>
        <ManagementAndGeneralAmt>38633</ManagementAndGeneralAmt>
      </FeesForServicesAccountingGrp>
      <FeesForServicesLobbyingGrp>
        <TotalAmt>0</TotalAmt>
      </FeesForServicesLobbyingGrp>
      <FeesForServicesProfFundraising>
        <TotalAmt>0</TotalAmt>
      </FeesForServicesProfFundraising>
      <FeesForSrvcInvstMgmntFeesGrp>
        <TotalAmt>17405</TotalAmt>
        <ManagementAndGeneralAmt>17405</ManagementAndGeneralAmt>
      </FeesForSrvcInvstMgmntFeesGrp>
      <FeesForServicesOtherGrp>
        <TotalAmt>230179</TotalAmt>
        <ProgramServicesAmt>227676</ProgramServicesAmt>
        <ManagementAndGeneralAmt>1118</ManagementAndGeneralAmt>
        <FundraisingAmt>1385</FundraisingAmt>
      </FeesForServicesOtherGrp>
      <AdvertisingGrp>
        <TotalAmt>9355</TotalAmt>
        <ProgramServicesAmt>4910</ProgramServicesAmt>
        <ManagementAndGeneralAmt>261</ManagementAndGeneralAmt>
        <FundraisingAmt>4184</FundraisingAmt>
      </AdvertisingGrp>
      <OfficeExpensesGrp>
        <TotalAmt>76</TotalAmt>
        <ProgramServicesAmt>20</ProgramServicesAmt>
        <ManagementAndGeneralAmt>56</ManagementAndGeneralAmt>
      </OfficeExpensesGrp>
      <InformationTechnologyGrp>
        <TotalAmt>16887</TotalAmt>
        <ProgramServicesAmt>10465</ProgramServicesAmt>
        <ManagementAndGeneralAmt>3692</ManagementAndGeneralAmt>
        <FundraisingAmt>2730</FundraisingAmt>
      </InformationTechnologyGrp>
      <RoyaltiesGrp>
        <TotalAmt>0</TotalAmt>
      </RoyaltiesGrp>
      <OccupancyGrp>
        <TotalAmt>0</TotalAmt>
      </OccupancyGrp>
      <TravelGrp>
        <TotalAmt>13477</TotalAmt>
        <ProgramServicesAmt>10267</ProgramServicesAmt>
        <ManagementAndGeneralAmt>2748</ManagementAndGeneralAmt>
        <FundraisingAmt>462</FundraisingAmt>
      </TravelGrp>
      <PymtTravelEntrtnmntPubOfclGrp>
        <TotalAmt>0</TotalAmt>
      </PymtTravelEntrtnmntPubOfclGrp>
      <ConferencesMeetingsGrp>
        <TotalAmt>0</TotalAmt>
      </ConferencesMeetingsGrp>
      <InterestGrp>
        <TotalAmt>0</TotalAmt>
      </InterestGrp>
      <PaymentsToAffiliatesGrp>
        <TotalAmt>0</TotalAmt>
      </PaymentsToAffiliatesGrp>
      <DepreciationDepletionGrp>
        <TotalAmt>577</TotalAmt>
        <ManagementAndGeneralAmt>577</ManagementAndGeneralAmt>
      </DepreciationDepletionGrp>
      <InsuranceGrp>
        <TotalAmt>6150</TotalAmt>
        <ProgramServicesAmt>1781</ProgramServicesAmt>
        <ManagementAndGeneralAmt>4128</ManagementAndGeneralAmt>
        <FundraisingAmt>241</FundraisingAmt>
      </InsuranceGrp>
      <OtherExpensesGrp>
        <Desc>Fiscal Sponsor Expenses</Desc>
        <TotalAmt>737481</TotalAmt>
        <ProgramServicesAmt>737481</ProgramServicesAmt>
      </OtherExpensesGrp>
      <OtherExpensesGrp>
        <Desc>In-kind services</Desc>
        <TotalAmt>20228</TotalAmt>
        <ProgramServicesAmt>300</ProgramServicesAmt>
        <FundraisingAmt>19928</FundraisingAmt>
      </OtherExpensesGrp>
      <OtherExpensesGrp>
        <Desc>Events</Desc>
        <TotalAmt>17549</TotalAmt>
        <ProgramServicesAmt>17504</ProgramServicesAmt>
        <ManagementAndGeneralAmt>45</ManagementAndGeneralAmt>
      </OtherExpensesGrp>
      <OtherExpensesGrp>
        <Desc>Honoraniums</Desc>
        <TotalAmt>16401</TotalAmt>
        <ProgramServicesAmt>16401</ProgramServicesAmt>
      </OtherExpensesGrp>
      <AllOtherExpensesGrp>
        <TotalAmt>11947</TotalAmt>
        <ProgramServicesAmt>6493</ProgramServicesAmt>
        <ManagementAndGeneralAmt>3191</ManagementAndGeneralAmt>
        <FundraisingAmt>2263</FundraisingAmt>
      </AllOtherExpensesGrp>
      <TotalFunctionalExpensesGrp>
        <TotalAmt>2056902</TotalAmt>
        <ProgramServicesAmt>1859196</ProgramServicesAmt>
        <ManagementAndGeneralAmt>116713</ManagementAndGeneralAmt>
        <FundraisingAmt>80993</FundraisingAmt>
      </TotalFunctionalExpensesGrp>
      <CashNonInterestBearingGrp>
        <BOYAmt>488670</BOYAmt>
        <EOYAmt>853875</EOYAmt>
      </CashNonInterestBearingGrp>
      <SavingsAndTempCashInvstGrp>
        <EOYAmt>0</EOYAmt>
      </SavingsAndTempCashInvstGrp>
      <PledgesAndGrantsReceivableGrp>
        <BOYAmt>711083</BOYAmt>
        <EOYAmt>368021</EOYAmt>
      </PledgesAndGrantsReceivableGrp>
      <AccountsReceivableGrp>
        <EOYAmt>0</EOYAmt>
      </AccountsReceivableGrp>
      <ReceivablesFromOfficersEtcGrp>
        <EOYAmt>0</EOYAmt>
      </ReceivablesFromOfficersEtcGrp>
      <RcvblFromDisqualifiedPrsnGrp>
        <EOYAmt>0</EOYAmt>
      </RcvblFromDisqualifiedPrsnGrp>
      <OthNotesLoansReceivableNetGrp>
        <EOYAmt>0</EOYAmt>
      </OthNotesLoansReceivableNetGrp>
      <InventoriesForSaleOrUseGrp>
        <EOYAmt>0</EOYAmt>
      </InventoriesForSaleOrUseGrp>
      <PrepaidExpensesDefrdChargesGrp>
        <EOYAmt>0</EOYAmt>
      </PrepaidExpensesDefrdChargesGrp>
      <LandBldgEquipCostOrOtherBssAmt>40422</LandBldgEquipCostOrOtherBssAmt>
      <LandBldgEquipAccumDeprecAmt>39267</LandBldgEquipAccumDeprecAmt>
      <LandBldgEquipBasisNetGrp>
        <EOYAmt>1155</EOYAmt>
      </LandBldgEquipBasisNetGrp>
      <InvestmentsPubTradedSecGrp>
        <EOYAmt>0</EOYAmt>
      </InvestmentsPubTradedSecGrp>
      <InvestmentsOtherSecuritiesGrp>
        <BOYAmt>2924071</BOYAmt>
        <EOYAmt>2564392</EOYAmt>
      </InvestmentsOtherSecuritiesGrp>
      <InvestmentsProgramRelatedGrp>
        <EOYAmt>0</EOYAmt>
      </InvestmentsProgramRelatedGrp>
      <IntangibleAssetsGrp>
        <EOYAmt>0</EOYAmt>
      </IntangibleAssetsGrp>
      <OtherAssetsTotalGrp>
        <EOYAmt>0</EOYAmt>
      </OtherAssetsTotalGrp>
      <TotalAssetsGrp>
        <BOYAmt>4123824</BOYAmt>
        <EOYAmt>3787443</EOYAmt>
      </TotalAssetsGrp>
      <AccountsPayableAccrExpnssGrp>
        <BOYAmt>19999</BOYAmt>
        <EOYAmt>152865</EOYAmt>
      </AccountsPayableAccrExpnssGrp>
      <DeferredRevenueGrp>
        <BOYAmt>280642</BOYAmt>
        <EOYAmt>138500</EOYAmt>
      </DeferredRevenueGrp>
      <OtherLiabilitiesGrp>
        <BOYAmt>262595</BOYAmt>
        <EOYAmt>192108</EOYAmt>
      </OtherLiabilitiesGrp>
      <TotalLiabilitiesGrp>
        <BOYAmt>563236</BOYAmt>
        <EOYAmt>483473</EOYAmt>
      </TotalLiabilitiesGrp>
      <OrganizationFollowsFASB117Ind>X</OrganizationFollowsFASB117Ind>
      <NoDonorRestrictionNetAssetsGrp>
        <BOYAmt>420037</BOYAmt>
        <EOYAmt>557205</EOYAmt>
      </NoDonorRestrictionNetAssetsGrp>
      <DonorRestrictionNetAssetsGrp>
        <BOYAmt>3140551</BOYAmt>
        <EOYAmt>2746765</EOYAmt>
      </DonorRestrictionNetAssetsGrp>
      <TotalNetAssetsFundBalanceGrp>
        <BOYAmt>3560588</BOYAmt>
        <EOYAmt>3303970</EOYAmt>
      </TotalNetAssetsFundBalanceGrp>
      <TotLiabNetAssetsFundBalanceGrp>
        <BOYAmt>4123824</BOYAmt>
        <EOYAmt>3787443</EOYAmt>
      </TotLiabNetAssetsFundBalanceGrp>
      <InfoInScheduleOPartXIInd>X</InfoInScheduleOPartXIInd>
      <ReconcilationRevenueExpnssAmt>96550</ReconcilationRevenueExpnssAmt>
      <NetUnrlzdGainsLossesInvstAmt>-351351</NetUnrlzdGainsLossesInvstAmt>
      <OtherChangesInNetAssetsAmt>-1817</OtherChangesInNetAssetsAmt>
      <InfoInScheduleOPartXIIInd>X</InfoInScheduleOPartXIIInd>
      <MethodOfAccountingAccrualInd>X</MethodOfAccountingAccrualInd>
      <AccountantCompileOrReviewInd>false</AccountantCompileOrReviewInd>
      <FSAuditedInd>true</FSAuditedInd>
      <FSAuditedBasisGrp>
        <ConsolidatedBasisFinclStmtInd>X</ConsolidatedBasisFinclStmtInd>
      </FSAuditedBasisGrp>
      <AuditCommitteeInd>true</AuditCommitteeInd>
      <FederalGrantAuditRequiredInd>false</FederalGrantAuditRequiredInd>
    </IRS990>
    <IRS990ScheduleA documentId="IRS990ScheduleA" softwareId="21013475" softwareVersionNum="2021v4.1">
      <PublicOrganization170Ind>X</PublicOrganization170Ind>
      <GiftsGrantsContriRcvd170Grp>
        <CurrentTaxYearMinus4YearsAmt>325485</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>803579</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>1153519</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>349850</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>1313014</CurrentTaxYearAmt>
        <TotalAmt>3945447</TotalAmt>
      </GiftsGrantsContriRcvd170Grp>
      <TaxRevLeviedOrgnztnlBnft170Grp>
        <TotalAmt>0</TotalAmt>
      </TaxRevLeviedOrgnztnlBnft170Grp>
      <GovtFurnSrvcFcltsVl170Grp>
        <TotalAmt>0</TotalAmt>
      </GovtFurnSrvcFcltsVl170Grp>
      <TotalCalendarYear170Grp>
        <CurrentTaxYearMinus4YearsAmt>325485</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>803579</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>1153519</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>349850</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>1313014</CurrentTaxYearAmt>
        <TotalAmt>3945447</TotalAmt>
      </TotalCalendarYear170Grp>
      <SubstantialContributorsTotAmt>1847556</SubstantialContributorsTotAmt>
      <PublicSupportTotal170Amt>2097891</PublicSupportTotal170Amt>
      <GrossInvestmentIncome170Grp>
        <CurrentTaxYearMinus4YearsAmt>63836</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>184374</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>74925</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>45071</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>121981</CurrentTaxYearAmt>
        <TotalAmt>490187</TotalAmt>
      </GrossInvestmentIncome170Grp>
      <UnrelatedBusinessNetIncm170Grp>
        <TotalAmt>0</TotalAmt>
      </UnrelatedBusinessNetIncm170Grp>
      <OtherIncome170Grp>
        <TotalAmt>0</TotalAmt>
      </OtherIncome170Grp>
      <TotalSupportAmt>4435634</TotalSupportAmt>
      <GrossReceiptsRltdActivitiesAmt>668826</GrossReceiptsRltdActivitiesAmt>
      <PublicSupportCY170Pct>0.47300</PublicSupportCY170Pct>
      <PublicSupportPY170Pct>0.42760</PublicSupportPY170Pct>
      <ThirtyThrPctSuprtTestsCY170Ind>X</ThirtyThrPctSuprtTestsCY170Ind>
    </IRS990ScheduleA>
    <IRS990ScheduleB documentId="IRS990ScheduleB" softwareId="21013475" softwareVersionNum="2021v4.1">
      <ContributorInformationGrp>
        <ContributorNum>RESTRICTED</ContributorNum>
        <ContributorBusinessName>
          <BusinessNameLine1>RESTRICTED</BusinessNameLine1>
        </ContributorBusinessName>
        <ContributorUSAddress>
          <AddressLine1>RESTRICTED</AddressLine1>
          <AddressLine2>RESTRICTED</AddressLine2>
          <City>RESTRICTED</City>
          <State>RESTRICTED</State>
          <ZIPCode>RESTRICTED</ZIPCode>
        </ContributorUSAddress>
        <TotalContributionsAmt>RESTRICTED</TotalContributionsAmt>
      </ContributorInformationGrp>
    </IRS990ScheduleB>
    <IRS990ScheduleD documentId="IRS990ScheduleD" softwareId="21013475" softwareVersionNum="2021v4.1">
      <CYEndwmtFundGrp>
        <BeginningYearBalanceAmt>2924071</BeginningYearBalanceAmt>
        <InvestmentEarningsOrLossesAmt>-264179</InvestmentEarningsOrLossesAmt>
        <AdministrativeExpensesAmt>95500</AdministrativeExpensesAmt>
        <EndYearBalanceAmt>2564392</EndYearBalanceAmt>
      </CYEndwmtFundGrp>
      <CYMinus1YrEndwmtFundGrp>
        <BeginningYearBalanceAmt>2565823</BeginningYearBalanceAmt>
        <ContributionsAmt>68213</ContributionsAmt>
        <InvestmentEarningsOrLossesAmt>568035</InvestmentEarningsOrLossesAmt>
        <AdministrativeExpensesAmt>278000</AdministrativeExpensesAmt>
        <EndYearBalanceAmt>2924071</EndYearBalanceAmt>
      </CYMinus1YrEndwmtFundGrp>
      <CYMinus2YrEndwmtFundGrp>
        <BeginningYearBalanceAmt>2615620</BeginningYearBalanceAmt>
        <ContributionsAmt>68394</ContributionsAmt>
        <InvestmentEarningsOrLossesAmt>-20166</InvestmentEarningsOrLossesAmt>
        <AdministrativeExpensesAmt>98025</AdministrativeExpensesAmt>
        <EndYearBalanceAmt>2565823</EndYearBalanceAmt>
      </CYMinus2YrEndwmtFundGrp>
      <CYMinus3YrEndwmtFundGrp>
        <BeginningYearBalanceAmt>2142643</BeginningYearBalanceAmt>
        <ContributionsAmt>554200</ContributionsAmt>
        <InvestmentEarningsOrLossesAmt>82277</InvestmentEarningsOrLossesAmt>
        <AdministrativeExpensesAmt>163500</AdministrativeExpensesAmt>
        <EndYearBalanceAmt>2615620</EndYearBalanceAmt>
      </CYMinus3YrEndwmtFundGrp>
      <CYMinus4YrEndwmtFundGrp>
        <BeginningYearBalanceAmt>2288461</BeginningYearBalanceAmt>
        <ContributionsAmt>4100</ContributionsAmt>
        <InvestmentEarningsOrLossesAmt>158074</InvestmentEarningsOrLossesAmt>
        <AdministrativeExpensesAmt>307992</AdministrativeExpensesAmt>
        <EndYearBalanceAmt>2142643</EndYearBalanceAmt>
      </CYMinus4YrEndwmtFundGrp>
      <PrmnntEndowmentBalanceEOYPct>0.69510</PrmnntEndowmentBalanceEOYPct>
      <TermEndowmentBalanceEOYPct>0.30490</TermEndowmentBalanceEOYPct>
      <EndowmentsHeldUnrelatedOrgInd>false</EndowmentsHeldUnrelatedOrgInd>
      <EndowmentsHeldRelatedOrgInd>false</EndowmentsHeldRelatedOrgInd>
      <RelatedOrgListSchRInd>false</RelatedOrgListSchRInd>
      <EquipmentGrp>
        <OtherCostOrOtherBasisAmt>40422</OtherCostOrOtherBasisAmt>
        <DepreciationAmt>39267</DepreciationAmt>
        <BookValueAmt>1155</BookValueAmt>
      </EquipmentGrp>
      <TotalBookValueLandBuildingsAmt>1155</TotalBookValueLandBuildingsAmt>
      <TotalBookValueSecuritiesAmt>2564392</TotalBookValueSecuritiesAmt>
      <OtherLiabilitiesOrgGrp>
        <Desc>Accrued payroll liabilities</Desc>
        <Amt>17434</Amt>
      </OtherLiabilitiesOrgGrp>
      <OtherLiabilitiesOrgGrp>
        <Desc>Refundable advances</Desc>
        <Amt>174674</Amt>
      </OtherLiabilitiesOrgGrp>
      <TotalLiabilityAmt>192108</TotalLiabilityAmt>
      <FootnoteTextInd>X</FootnoteTextInd>
      <TotalRevEtcAuditedFinclStmtAmt>1794076</TotalRevEtcAuditedFinclStmtAmt>
      <NetUnrealizedGainsInvstAmt>-351351</NetUnrealizedGainsInvstAmt>
      <OtherRevenueAmt>9380</OtherRevenueAmt>
      <RevenueNotReportedAmt>-341971</RevenueNotReportedAmt>
      <RevenueSubtotalAmt>2136047</RevenueSubtotalAmt>
      <InvestmentExpensesNotIncldAmt>17405</InvestmentExpensesNotIncldAmt>
      <RevenueNotReportedFinclStmtAmt>17405</RevenueNotReportedFinclStmtAmt>
      <TotalRevenuePerForm990Amt>2153452</TotalRevenuePerForm990Amt>
      <TotExpnsEtcAuditedFinclStmtAmt>2050694</TotExpnsEtcAuditedFinclStmtAmt>
      <OtherExpensesIncludedAmt>11197</OtherExpensesIncludedAmt>
      <ExpensesNotReportedAmt>11197</ExpensesNotReportedAmt>
      <ExpensesSubtotalAmt>2039497</ExpensesSubtotalAmt>
      <InvestmentExpensesNotIncld2Amt>17405</InvestmentExpensesNotIncld2Amt>
      <ExpensesNotRptFinclStmtAmt>17405</ExpensesNotRptFinclStmtAmt>
      <TotalExpensesPerForm990Amt>2056902</TotalExpensesPerForm990Amt>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Part V, Line 4: Intended uses of the endowment fund.</FormAndLineReferenceDesc>
        <ExplanationTxt>VC is subject to the Uniform Prudent Management of Institutional Funds Act (UPMIFA and the California equivalent enacted by SB 1329 in California) which requires the preservation of the fair value of the original gift as of the gift date of the donor-restricted Madden and Margaret N. Stiegele Endowments absent explicit donor stipulations to the contrary. VC therefore classifies as net assets with donor restrictions perpetual in nature (a) the original value of gifts donated to the permanent Madden and Margaret N. Stiegele Endowments and (b) the original value of subsequent gifts to the permanent Madden and Margaret N. Stiegele Endowments.The remaining portion of the donor-restricted Madden and Margaret N. Stiegele Endowments not classified in net assets with donor restrictions perpetual in nature is classified as net assets with donor restrictions time or purpose until those amounts are appropriated for expenditure by the organization in a manner consistent with the standard of prudence prescribed by UPMIFA.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Part X : FIN48 Footnote</FormAndLineReferenceDesc>
        <ExplanationTxt>Income TaxesFinancial statement presentation follows the recommendations of ASC 740, Income Taxes. Under ASC 740, Vascular Cures (VC) is required to report information regarding its exposure to various tax positions taken by VC and requires a two-step process that separates recognition from measurement. The first step is determining whether a tax position has met the recognition threshold; the second step is measuring a tax position that meets the recognition threshold. Management believes that VC has adequately evaluated its current tax positions and has concluded that as of June 30, 2022, VC does not have any uncertain tax positions for which a reserve or an accrual for a tax liability would be necessary.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Part XI, Line 2d: Other revenue amounts included in F/S but not included on form 990</FormAndLineReferenceDesc>
        <ExplanationTxt>Special Events Expenses $11197 Change in discount $-1817</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Part XII, Line 2d: Other expenses and losses per audited F/S</FormAndLineReferenceDesc>
        <ExplanationTxt>Special Events Expenses $11197</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleD>
    <IRS990ScheduleF documentId="IRS990ScheduleF" softwareId="21013475" softwareVersionNum="2021v4.1">
      <GrantRecordsMaintainedInd>true</GrantRecordsMaintainedInd>
      <AccountActivitiesOutsideUSGrp>
        <RegionTxt>North America</RegionTxt>
        <OfficesCnt>0</OfficesCnt>
        <EmployeeCnt>0</EmployeeCnt>
        <TypeOfActivitiesConductedTxt>Health Care</TypeOfActivitiesConductedTxt>
        <SpecificServicesProvidedTxt>Grant to fund medical research</SpecificServicesProvidedTxt>
        <RegionTotalExpendituresAmt>100000</RegionTotalExpendituresAmt>
      </AccountActivitiesOutsideUSGrp>
      <SubtotalSpentAmt>100000</SubtotalSpentAmt>
      <TotalSpentAmt>100000</TotalSpentAmt>
      <GrantsToOrgOutsideUSGrp>
        <RegionTxt>North America</RegionTxt>
        <PurposeOfGrantTxt>Research</PurposeOfGrantTxt>
        <CashGrantAmt>50000</CashGrantAmt>
        <MannerOfCashDisbursementTxt>Cash Payment</MannerOfCashDisbursementTxt>
      </GrantsToOrgOutsideUSGrp>
      <GrantsToOrgOutsideUSGrp>
        <RegionTxt>North America</RegionTxt>
        <PurposeOfGrantTxt>Research</PurposeOfGrantTxt>
        <CashGrantAmt>50000</CashGrantAmt>
        <MannerOfCashDisbursementTxt>Cash Payment</MannerOfCashDisbursementTxt>
      </GrantsToOrgOutsideUSGrp>
      <Total501c3OrgCnt>1</Total501c3OrgCnt>
      <TotalOtherOrgCnt>1</TotalOtherOrgCnt>
      <TransferToForeignCorpInd>false</TransferToForeignCorpInd>
      <InterestInForeignTrustInd>false</InterestInForeignTrustInd>
      <ForeignCorpOwnershipInd>false</ForeignCorpOwnershipInd>
      <PassiveForeignInvestmestCoInd>false</PassiveForeignInvestmestCoInd>
      <ForeignPartnershipInd>false</ForeignPartnershipInd>
      <BoycottCountriesInd>false</BoycottCountriesInd>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Part I, Line 2 - Grantmakers Explanation For Monitoring Use of Funds Outside US</FormAndLineReferenceDesc>
        <ExplanationTxt>After funding is approved, the recipient organization must sign letter of agreement confirming the terms of the grant. Financial and Narrative Reports are required to ensure funds are spent in accordance with the agreement. Expenditures are made against budgeted amounts and analyzed by US-based management. Discussions, e-mails, and other techniques of communication are employed to ensure that funds are utilized according to the original intent.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Part I, Line 3f - Method of Accounting</FormAndLineReferenceDesc>
        <ExplanationTxt>Cash basis method of accounting is utilized.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Part II, Line 1 - Method of Accounting</FormAndLineReferenceDesc>
        <ExplanationTxt>Cash Basis method of accounting is followed.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleF>
    <IRS990ScheduleG documentId="IRS990ScheduleG" softwareId="21013475" softwareVersionNum="2021v4.1">
      <MailSolicitationsInd>X</MailSolicitationsInd>
      <EmailSolicitationsInd>X</EmailSolicitationsInd>
      <PhoneSolicitationsInd>X</PhoneSolicitationsInd>
      <InPersonSolicitationsInd>X</InPersonSolicitationsInd>
      <SolicitationOfNonGovtGrantsInd>X</SolicitationOfNonGovtGrantsInd>
      <SpecialFundraisingEventsInd>X</SpecialFundraisingEventsInd>
      <AgrmtProfFundraisingActyInd>false</AgrmtProfFundraisingActyInd>
      <LicensedStatesCd>CA</LicensedStatesCd>
      <FundraisingEventInformationGrp>
        <Event1Nm>Annual Dinner</Event1Nm>
        <GrossReceiptsEvent1Amt>80988</GrossReceiptsEvent1Amt>
        <GrossRevenueEvent1Amt>80988</GrossRevenueEvent1Amt>
        <OtherDirectExpensesEvent1Amt>11197</OtherDirectExpensesEvent1Amt>
        <GrossReceiptsTotalAmt>80988</GrossReceiptsTotalAmt>
        <GrossRevenueTotalEventsAmt>80988</GrossRevenueTotalEventsAmt>
        <OthDirectExpnssTotalEventsAmt>11197</OthDirectExpnssTotalEventsAmt>
        <DirectExpenseSummaryEventsAmt>11197</DirectExpenseSummaryEventsAmt>
        <NetIncomeSummaryAmt>69791</NetIncomeSummaryAmt>
      </FundraisingEventInformationGrp>
    </IRS990ScheduleG>
    <IRS990ScheduleI documentId="IRS990ScheduleI" softwareId="21013475" softwareVersionNum="2021v4.1">
      <GrantRecordsMaintainedInd>true</GrantRecordsMaintainedInd>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>CASA COLINA HOSPITAL CENTERS</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>255 E BONITA AVENUE</AddressLine1Txt>
          <CityNm>POMONA</CityNm>
          <StateAbbreviationCd>CA</StateAbbreviationCd>
          <ZIPCd>91767</ZIPCd>
        </USAddress>
        <RecipientEIN>951643989</RecipientEIN>
        <CashGrantAmt>50000</CashGrantAmt>
        <NonCashAssistanceAmt>0</NonCashAssistanceAmt>
        <PurposeOfGrantTxt>Research</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>Duke University</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>BOX 104132</AddressLine1Txt>
          <CityNm>Durham</CityNm>
          <StateAbbreviationCd>NC</StateAbbreviationCd>
          <ZIPCd>27708</ZIPCd>
        </USAddress>
        <RecipientEIN>562070036</RecipientEIN>
        <CashGrantAmt>100000</CashGrantAmt>
        <NonCashAssistanceAmt>0</NonCashAssistanceAmt>
        <PurposeOfGrantTxt>Research</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>UNIVERSITY OF FLORIDA</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>207 GRINTER HALL</AddressLine1Txt>
          <CityNm>GAINESVILLE</CityNm>
          <StateAbbreviationCd>FL</StateAbbreviationCd>
          <ZIPCd>32611</ZIPCd>
        </USAddress>
        <RecipientEIN>596002052</RecipientEIN>
        <CashGrantAmt>39000</CashGrantAmt>
        <NonCashAssistanceAmt>0</NonCashAssistanceAmt>
        <PurposeOfGrantTxt>Research</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>UNIVERSITY OF MASSACHUSETTS</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>281 LINCOLN STREET</AddressLine1Txt>
          <CityNm>WORCESTER</CityNm>
          <StateAbbreviationCd>MA</StateAbbreviationCd>
          <ZIPCd>01605</ZIPCd>
        </USAddress>
        <RecipientEIN>986000971</RecipientEIN>
        <CashGrantAmt>50000</CashGrantAmt>
        <NonCashAssistanceAmt>0</NonCashAssistanceAmt>
        <PurposeOfGrantTxt>Research</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>University of Michigan</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>515 E Jefferson St</AddressLine1Txt>
          <CityNm>ANN ARBOR</CityNm>
          <StateAbbreviationCd>MI</StateAbbreviationCd>
          <ZIPCd>48109</ZIPCd>
        </USAddress>
        <RecipientEIN>386006309</RecipientEIN>
        <CashGrantAmt>50000</CashGrantAmt>
        <NonCashAssistanceAmt>0</NonCashAssistanceAmt>
        <PurposeOfGrantTxt>Research</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>University of Pittsburgh</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>600 GRANT STREET</AddressLine1Txt>
          <CityNm>Pittsburgh</CityNm>
          <StateAbbreviationCd>PA</StateAbbreviationCd>
          <ZIPCd>15219</ZIPCd>
        </USAddress>
        <RecipientEIN>251423657</RecipientEIN>
        <CashGrantAmt>30800</CashGrantAmt>
        <NonCashAssistanceAmt>0</NonCashAssistanceAmt>
        <PurposeOfGrantTxt>Research</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>Vanderbilt University</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>1161 21ST AVE S D-3300 Med C</AddressLine1Txt>
          <CityNm>NASHVILLE</CityNm>
          <StateAbbreviationCd>TN</StateAbbreviationCd>
          <ZIPCd>37232</ZIPCd>
        </USAddress>
        <RecipientEIN>352528741</RecipientEIN>
        <CashGrantAmt>5600</CashGrantAmt>
        <NonCashAssistanceAmt>0</NonCashAssistanceAmt>
        <PurposeOfGrantTxt>Research</PurposeOfGrantTxt>
      </RecipientTable>
      <Total501c3OrgCnt>7</Total501c3OrgCnt>
      <TotalOtherOrgCnt>0</TotalOtherOrgCnt>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Additional Supplemental Information</FormAndLineReferenceDesc>
        <ExplanationTxt>Part I, Line 2:The grant recipient sends an annual report which details the research performed, results achieved, and use of funds as well as a budget for the following year.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Grantmaker's Description of How Grants are Used</FormAndLineReferenceDesc>
        <ExplanationTxt>Vascular Cures performs ongoing oversight for all projects for which funds are provided. This includes written correspondence, emails, telephone calls, and other methods.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleI>
    <IRS990ScheduleO documentId="IRS990ScheduleO" softwareId="21013475" softwareVersionNum="2021v4.1">
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part III, Line 4d: Other Program Services Description</FormAndLineReferenceDesc>
        <ExplanationTxt>OTHER PROGRAM SERVICES 4: OUR PATIENTS AS PARTNERS PROGRAM IS DESIGNED TO FACILITATE THE ENGAGEMENT OF PATIENTADVISORS IN NATIONAL RESEARCH AND CARE IMPROVEMENT INITIATIVES. WE ARE ALSOINTERESTED IN ENGAGING CAREGIVERS AND FAMILY MEMBERS IMPACTED BY VASCULAR DISEASE.WE ARE FOSTERING A COMMUNITY OF REPRESENTATIVE, EMPOWERED ADVOCATES TO CLAIM THEIRSEAT TO THE TABLE AS TRUE PARTNERS. OTHER PROGRAM SERVICES 5: WE SERVE AS THE FISCAL SPONSOR OF AMERICAN LIMB PRESERVATION SOCIETY. WHEN WE LAUNCHED PROJECT VOICE, IT WAS THE FIRST DIGITAL HEALTH PROGRAM TO IMPROVEOUTCOMES FOR PATIENTS WITH PERIPHERAL ARTERY DISEASE (PAD). PROJECT VOICE WILL 1)BRING PATIENTS INTO THE HEALTHCARE CONVERSATION, MANAGE THEIR OWN HEALTH AND SHAREIN DECISION-MAKING; 2) ENABLE RESEARCHERS TO GATHER PATIENT-REPORTED OUTCOMES DATA,CURRENTLY A CRUCIAL GAP IN BOTH RESEARCH AND HEALTHCARE AND 3) IMPROVEPATIENT-PHYSICIAN PARTNERSHIPS THROUGH HIGHER QUALITY INFORMATION EXCHANGE ANDSHARED DECISION-MAKING. THE ULTIMATE GOAL IS TO IMPROVE OUTCOMES AND LOWERHEALTHCARE COSTS. OTHER PROGRAM SERVICES 6: WE HAVE CONVENED WORKING GROUPS TO PROMOTE AND FACILITATE CHRONIC LIMB-THREATENINGISCHEMIA (CLTI) PATIENT ENGAGEMENT IN RESEARCH. THIS INITIATIVE WILL BUILD CAPACITYTO ENGAGE CLTI PATIENTS IN RESEARCH AS ADVISORS AND PARTICIPANTS, SO THAT STUDYRESULTS ALIGN WITH THE NEEDS OF THE PATIENT. IT WILL ALSO PRIORITIZE THE KINDS OFRESEARCH THAT ARE MOST IMPORTANT TO PATIENTS.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part VI, Line 11b: Form 990 Review Process</FormAndLineReferenceDesc>
        <ExplanationTxt>Form 990 is prepared by an outside tax professional. The form is then reviewed by the organization's management. After a full review, the final version of the tax return is provided to all members of the organization's voting body. A representative of management authorizes the final form 990 which is then e-filed with the internal revenue service.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part VI, Line 12c: Explanation of Monitoring and Enforcement of Conflicts</FormAndLineReferenceDesc>
        <ExplanationTxt>Members of the Board of Directors review all potential conflicts of interest periodically. Top management and all Board members are required to disclose potential conflicts and any related party affiliations. The organization seeks full transparency on all relationships. Any potential conflicts (in fact or appearance) are discussed openly and resolved in accordance with the organization's policies and procedures.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part VI, Line 15a: Compensation Review &amp; Approval Process - CEO, Top Management</FormAndLineReferenceDesc>
        <ExplanationTxt>Members of the board of directors review the compensation of all high-level personnel periodically in accordance with IRS rules and regulations. Efforts are made to secure compensation data from industry sources in order to determine competitiveness and appropriateness of salaries. Every effort is made to ensure that the process is thorough and transparent in accordance with IRS guidelines and the organization's policies and procedures.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part VI, Line 15b: Compensation Review and Approval Process for Officers and Key Employees</FormAndLineReferenceDesc>
        <ExplanationTxt>Compensation of other personnel and highly compensated employees is reviewed periodically by members of management. Efforts are made to secure compensation data from industry sources in order to determine competitiveness and appropriateness of salaries and all related benefits. All decisions are then documented in personnel files.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part VI, Line 19: Other Organization Documents Publicly Available</FormAndLineReferenceDesc>
        <ExplanationTxt>All of the organization's governing documents, financial statements, and other legal filings are maintained in a secure environment and held available for inspection by tax authorities and the general public. Tax returns are posted annually to our website and to www.guidestar.org (where they are available for viewing as electronic copies) and are also available by request from the organization's office.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Other Changes In Net Assets Or Fund Balances - Other Decreases</FormAndLineReferenceDesc>
        <ExplanationTxt>Change in unamortized discount = -$1817</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part XII, Line 2: Change of Oversight or Selection Process</FormAndLineReferenceDesc>
        <ExplanationTxt>Under the California Nonprofit Integrity Act, an exempt organization with annual revenue of $2 million or more is required to have an Audit Committee to select an audit Firm, review the audit, and approve the audit of its annual financial statements.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Part III Line 4c continued</FormAndLineReferenceDesc>
        <ExplanationTxt>We Bring awareness to the public re: the importance of vascular health, the kinds of vascular conditions and their signs and symptomsWe Educate at-risk communities and individuals re: the signs and symptoms of vascular diseases, major risk factors, strategies to reduce risk and the diagnostic processWe Empower patients to improve their health outcomes through education that enables better disease management and self-advocacy in a care settingWe Educate providers on the importance of vascular health, underdiagnosed conditions such as PAD</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleO>
  </ReturnData>
</Return>
